A detailed history of Eldred Rock Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Eldred Rock Partners, LLC holds 41,690 shares of NVO stock, worth $5.66 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares
41,690
Previous 30,970 34.61%
Holding current value
$5.66 Million
Previous $3.98 Billion 49.65%
% of portfolio
2.49%
Previous 2.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $1.32 Million - $1.57 Million
10,720 Added 34.61%
41,690 $5.95 Billion
Q1 2024

Apr 11, 2024

SELL
$102.11 - $135.92 $273,961 - $364,673
-2,683 Reduced 7.97%
30,970 $3.98 Billion
Q4 2023

Jan 11, 2024

BUY
$87.78 - $105.45 $2.95 Million - $3.55 Million
33,653 New
33,653 $3.48 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $307B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Eldred Rock Partners, LLC Portfolio

Follow Eldred Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldred Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eldred Rock Partners, LLC with notifications on news.